...
首页> 外文期刊>International psychogeriatrics >The 'CHROME criteria': Tool to optimize and audit prescription quality of psychotropic medications in institutionalized people with dementia
【24h】

The 'CHROME criteria': Tool to optimize and audit prescription quality of psychotropic medications in institutionalized people with dementia

机译:“Chrome标准”:在痴呆症的制度化人物中优化和审计精神药物处方质量的工具

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: Describe and validate the CHROME (CHemical Restraints avOidance MEthodology) criteria.Design: Observational prospective longitudinal study.Setting: Single nursing home in Las Palmas de Gran Canaria, Spain.Participants: 288 residents; mean age: 81.6 (SD 10.6). 77.4% had dementia.Intervention: Multicomponent training and consultancy program to eliminate physical and chemical restraints and promote overall quality care. Clinicians were trained in stringent diagnostic criteria of neuropsychiatric syndromes and adequate psychotropic prescription.Measurements: Psychotropic prescription (primary study target), neuropsychiatric syndromes, physical restraints, falls, and emergency room visits were semi-annually collected from December 2015 to December 2017. Results are presented for all residents and for those who had dementia and participated in the five study waves (completer analysis, w=107).Results: For the study completers, atypical neuroleptic prescription dropped from 42.7% to 18.7%, long half-life benzodiazepines dropped from 25.2% to 6.5%, and hypnotic medications from 47.7% to 12.1% (p<0.0005). Any kind of fall evolved from 67.3 to 32.7 (number of falls by 100 residents per year). Physicians' diagnostic confidence increased, while the frequency of diagnoses of neuropsychiatric syndromes decreased (p<0.0005).Conclusions: Implementing the CHROME criteria reduced the prescription of the most dangerous medications in institutionalized people with dementia. Two independent audits found no physical or chemical restraint and confirmed prescription quality of psychotropic drugs. Adequate diagnosis and independent audits appear to be the keys to help and motivate professionals to optimize and reduce the use of psychotropic medication. The CHROME criteria unify, in a single compendium, neuropsychiatric diagnostic criteria, prescription guidelines, independent audit methodology, and minimum legal standards. These criteria can be easily adapted to other countries.
机译:目的:描述和验证Chrome(化学抑制避免方法)条款。设计:观察前瞻性纵向学习。Setting:Setting:Singling Home在Las Palmas de Gran Canaria,Spain .participants:288名居民;平均年龄:81.6(SD 10.6)。 77.4%有痴呆症。专业:多组分培训和咨询计划,消除了物理和化学抑制,促进了整体优质护理。临床医生受到严格诊断标准的神经精神症综合征的严格诊断标准和足够的精神药物处方。从2015年12月到2017年12月,精神病毒处方(初级研究靶标),神经精神综合征,身体抑制,跌倒和急诊室访问。结果是为所有居民提供的,并且那些患有痴呆症的人并参加了五个研究波(随意分析,W = 107)。结果:对于研究完成方案,非典型的神经抑制方案从42.7%下降到18.7%,长半衰期苯并二氮卓从25.2%降至6.5%,催眠药从47.7%到12.1%(P <0.0005)。任何类型的秋天从67.3到32.7(每年100个居民的跌幅)发展。医生的诊断置信度增加,而神经精神综合征诊断的频率降低(P <0.0005)。结论:实施铬标准将最危险药物的处方减少,患有痴呆症的制度化人民中最危险的药物。两项独立审计发现没有物理或化学抑制,并确认了精神药物的处方质量。充分的诊断和独立审计似乎是帮助和激励专业人士优化和减少精神药物使用的钥匙。 Chrome标准统一,在单一的纲要,神经精神诊断标准,处方指南,独立审计方法和最低法律标准中。这些标准可以很容易地适应其他国家。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号